CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 76 enrolled
Drug / intervention
Saline +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02240628
NCT02240628Phase 4Completed

In Children, Placing a Synera Patch for Intravenous Access Combined With Administration of a Propofol-Lidocaine Mixture Decreases Pain Associated With Propofol Intravenous Injection.

The University of Texas Health Science Center, Houston·interventional·Posted Sep 15, 2014·Updated Jun 22, 2016

In Brief

A Phase 4 clinical trial evaluating Lidocaine/tetracaine transdermal patch, Saline, and 1 other intervention for Pain on IV Injection of Propofol.. Completed, enrolled 76 participants across 1 site.

Detailed Summary

The main objective is to evaluate if combining placing the Synera patch and using Propofol /Lidocaine mixture will further decrease the pain associated with the IV injection of Propofol.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 15, 2014
Enrollment StartAug 1, 2014
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 11.8 years ago

Interventions

Lidocaine/tetracaine transdermal patchdevice

All patients in arm 1 and arm 2 will receive the Synera Patch.

Salinedrug

Patients in arm 2 will receive Saline with the Propofol.

Lidocainedrug

Patients in arm 1 will receive Lidocaine with the Propofol.